The Mallinckrodt 2020
Advancing ECP Immunomodulation Investigator Award
Call for proposals
After last year’s successful initiation of the “Advancing THERAKOS ECP ImmunomodulationTM Award”
programme, Mallinckrodt, the global leader in extracorporeal photopheresis (ECP), is proud to renew its commitment
with the 2020 edition of this programme, part of its mission to continue advancing the science of ECP.
Whether you are a clinician or a scientist involved, or interested, in ECP Immunomodulation, you and your team
may be eligible to apply for this award.
The ECP Investigator Award 2019
In March 2019, Mallinckrodt announced the recipient of the 2019 Investigator Award – Newcastle University, in collaboration with Medical University, Graz and Newcastle Hospitals NHS Foundation Trust. The winning entry was submitted by co-investigator Dr. Rachel Crossland, alongside collaborators Prof. Anne Dickinson, Prof. Hildegard Greinix and Dr. Aisling Flinn.
The ECP Investigator Award 2018
In March 2018, Mallinckrodt announced the first honorees of the company’s Advancing Extracorporeal Photopheresis (ECP) Immunomodulation Investigator Award – investigator Dr. Nick Matthews and co-investigator Dr. Arun Alfred of the Department of Haematology at Rotherham NHS Foundation Trust in the United Kingdom.
Investigator Initiated Research
The mission of the Investigator Initiated Research (IIR) Program at Mallinckrodt is to improve the
lives of our patients by increasing the medical and scientific understanding of our products and
related therapeutic areas.
Independent Medical Education Grants
Mallinckrodt is committed to supporting independent, high-quality educational programmes for healthcare professionals that contribute to the improvement of patient care in the therapeutic areas in which the business has research and commercial interests.